(Reuters) - Biocon Ltd, India's biggest biotechnology firm, posted a 46 percent fall in third-quarter profit on Wednesday hurt by an increase in interest and depreciation costs related to its Malaysia operations.
Profit fell to 919 million rupees ($14.43 million) in the quarter ended Dec. 31, compared with 1.71 billion rupees a year earlier. https://bsmedia.business-standard.combit.ly/2rvTd8e
Revenue from operations rose 1.3 percent to 10.58 billion rupees.
($1 = 63.6900 Indian rupees)
(Reporting by Jessica Kuruthukulangara in Bengaluru; Editing by Supriya Kurane)
Disclaimer: No Business Standard Journalist was involved in creation of this content